Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Antonio G. Richetta"'
Autor:
Diego Orsini, Giacomo Caldarola, Annunziata Dattola, Elena Campione, Nicoletta Bernardini, Pasquale Frascione, Clara De Simone, Antonio G. Richetta, Marco Galluzzo, Nevena Skroza, Chiara Assorgi, Emanuele Amore, Gennaro M. Falco, Ruslana Gaeta Shumak, Fabio Artosi, Giulia Maretti, Concetta Potenza, Luca Bianchi, Giovanni Pellacani, Ketty Peris, Claudio Bonifati, Dario Graceffa
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
Purpose of the article: Interleukin-23 inhibitors, such as tildrakizumab, have emerged as safe and effective options for the management of psoriasis. Yet their efficacy in elderly patients (aged 65 years or more), particularly in those with difficult
Externí odkaz:
https://doaj.org/article/6ed0bed7541c4a9084145e7ddf8bf2a1
Autor:
Diego Orsini, Piergiorgio Malagoli, Anna Balato, Luca Bianchi, Pina Brianti, Dario Buononato, Martina Burlando, Giacomo Caldarola, Anna Campanati, Elena Campione, Carlo G. Carrera, Andrea Carugno, Francesco Cusano, Paolo Dapavo, Annunziata Dattola, Clara De Simone, Valentina Dini, Maria Esposito, Maria C. Fargnoli, Francesca M. Gaiani, Luigi Gargiulo, Paolo Gisondi, Alessandro Giunta, Luciano Ibba, Claudia Lasagni, Francesco Loconsole, Vincenzo Maione, Edoardo Mortato, Angelo V. Marzano, Martina Maurelli, Matteo Megna, Santo R. Mercuri, Alessandra Narcisi, Annamaria Offidani, Giovanni Paolino, Aurora Parodi, Giovanni Pellacani, Luca Potestio, Pietro Quaglino, Antonio G. Richetta, Francesca Romano, Paolo Sena, Marina Venturini, Chiara Assorgi, Antonio Costanzo
Publikováno v:
Dermatology Practical & Conceptual, Vol 14, Iss 2 (2024)
Introduction: Genital involvement is observed in approximately 60% of patients with psoriasis, presenting clinicians with formidable challenges in treatment. While new biologic drugs have emerged as safe and effective options for managing psoriasis,
Externí odkaz:
https://doaj.org/article/59fd209fd8eb441cabd179657001da3a
Autor:
Luigi Gargiulo, Alessandra Narcisi, Luciano Ibba, Anna Balato, Luca Bianchi, Pina Brianti, Dario Buononato, Martina Burlando, Giacomo Caldarola, Anna Campanati, Elena Campione, Carlo G. Carrera, Andrea Carugno, Antonio Cristaudo, Francesco Cusano, Paolo Dapavo, Annunziata Dattola, Clara De Simone, Francesca M. Gaiani, Paolo Gisondi, Alessandro Giunta, Francesco Loconsole, Vincenzo Maione, Edoardo Mortato, Angelo V. Marzano, Martina Maurelli, Matteo Megna, Santo R. Mercuri, Annamaria Offidani, Diego Orsini, Aurora Parodi, Giovanni Pellacani, Luca Potestio, Pietro Quaglino, Antonio G. Richetta, Francesca Romano, Paolo Sena, Marina Venturini, Piergiorgio Malagoli, Antonio Costanzo
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionBimekizumab is a monoclonal antibody that targets Interleukin-17 A and F, approved for the treatment of moderate-to-severe plaque psoriasis. While bimekizumab has been evaluated in several phase-III clinical trials, real-world evidence is
Externí odkaz:
https://doaj.org/article/a57a586330ad40f1847d355dbee4ceef
Multimethod and Interpersonal Assessment in Medical Settings: A Case Study from the Dermatology Unit
Autor:
Chiara Vari, Patrizia Velotti, Giulio Cesare Zavattini, Antonio G. Richetta, Stefano Calvieri
Publikováno v:
Mediterranean Journal of Clinical Psychology, Vol 1, Iss 3 (2014)
Psoriasis is a chronic skin disease with multifactorial aetiology. The psychological impact of skin diseases is increasingly recognised, but only scant attention has been given to the possible role of couple relationships as protective factors for de
Externí odkaz:
https://doaj.org/article/7870f3f2c6194bc2a4366d3a2562178b
Autor:
Ugo BOTTONI, Rita CLERICO, Antonio G. RICHETTA, Vincenzo PANASITI, Paola CORSETTI, Vincenzo ROBERTI, Giovanni PAOLINO, Elisa MOLITERNI, Sara GRASSI, Stefano CALVIERI
Publikováno v:
Italian Journal of Dermatology and Venereology. 158
Autor:
Federica MARRAFFA, Agneszka DYBALA, Sara GRASSI, Federica REGA, Vincenzo ROBERTI, Andrea VIZZACCARO, Simone MICHELINI, Giovanni PELLACANI, Antonio G. RICHETTA
Publikováno v:
Italian journal of dermatology and venereology. 157(5)
Autor:
Carmen, Cantisani, Tamara, Lazic, Antonio G, Richetta, Rita, Clerico, Carlo, Mattozzi, Stefano, Calvieri
Imiquimod is an immune response modifier that stimulates the patient's own immune system to release various chemical substances, such as interferon and interleukin-12. Although, approved by the United States Food and Drug Administration since 1997 as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0e5b67b4f938d0da383b6cc0af950849
http://hdl.handle.net/11573/436357
http://hdl.handle.net/11573/436357
Psoriasis is a common, inflammatory, chronic, relapsing skin disease. New insight about the etiology of this disease shows the important role played by the epidermal barrier function, its integrity and pathogen responses in combination with microbial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::69311f793001748f59505ab0b415f364
http://hdl.handle.net/11573/495606
http://hdl.handle.net/11573/495606
Autor:
Antonio G, Richetta, Carlo, Mattozzi, Elisa, Maiani, Valentina, Carboni, Valentina, Carlomagno, Manuela, Cimillo, Simona, Giancristoforo, Sara, D'Epiro, Stefano, Calvieri
Systemic vasculitis is a group of heterogeneous diseases characterized by inflammation and blood vessel walls necrosis. Usually the skin is one of the first organs involved, especially with damage of small to medium size vessels. The cutaneous patter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0841541898359362919ec2dee8fc7d97
http://hdl.handle.net/11573/909351
http://hdl.handle.net/11573/909351